Prosecution Insights
Last updated: April 19, 2026

Center For Excellence In Molecular Cell Science Chinese Academy Of Sciences

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18270917 FULLY HUMAN BROAD-SPECTRUM NEUTRALIZING ANTIBODY 76E1 AGAINST CORONAVIRUS, AND USE THEREOF GRIZER, CASSANDRA SENN 1672 Non-Final OA Jul 05, 2023
18248443 Method for Inducing Differentiated Cells Into Pluripotent Endoderm Stem Cells and Application Thereof STAVROU, CONSTANTINA E 1632 Non-Final OA Apr 10, 2023
17789378 APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES LANKFORD JR, LEON B 1657 Non-Final OA Jun 27, 2022
17292296 USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG ROGERS, ERIC JASON 1638 Final Rejection Sep 15, 2021
17290767 APPLICATION OF ECM1 IN PREVENTION AND/OR TREATMENT OF LIVER FIBROSIS-RELATED DISEASES KATAKAM, SUDHAKAR 1658 Non-Final OA Jul 27, 2021

Managing Center For Excellence In Molecular Cell Science Chinese Academy Of Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month